|
KLHL20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.401300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.430670E-04 |
| Normal-vs-Stage2 |
7.122500E-02 |
| Normal-vs-Stage3 |
5.653400E-01 |
| Normal-vs-Stage4 |
1.158020E-02 |
| Stage1-vs-Stage2 |
5.927000E-01 |
| Stage1-vs-Stage3 |
5.742200E-02 |
| Stage1-vs-Stage4 |
8.276000E-01 |
| Stage2-vs-Stage3 |
3.267800E-01 |
| Stage2-vs-Stage4 |
5.463400E-01 |
| Stage3-vs-Stage4 |
1.866050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.274360E-02 |
| Normal-vs-AfricanAmerican |
3.660300E-03 |
| Normal-vs-Asian |
5.181400E-01 |
| Caucasian-vs-AfricanAmerican |
5.038000E-01 |
| Caucasian-vs-Asian |
7.676600E-01 |
| AfricanAmerican-vs-Asian |
4.854600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.818010E-03 |
| Normal-vs-Female |
4.408800E-01 |
| Male-vs-Female |
7.428000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.037800E-03 |
| Normal-vs-Extreme_Weight |
1.54247999999413E-05 |
| Normal-vs-Obese |
2.944200E-01 |
| Normal-vs-Extreme_Obese |
7.855100E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.955000E-01 |
| Normal_Weight-vs-Obese |
1.543000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.198400E-01 |
| Extreme_Weight-vs-Obese |
2.648500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.796000E-01 |
| Obese-vs-Extreme_Obese |
3.088200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.888800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.817700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.761500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.217700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.033600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.996840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.578590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.493900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.090200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.371800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.608400E-04 |
| Normal-VS-Type2 PRCC |
7.404400E-02 |
| Normal-VS-KIRP CIMP |
8.690800E-01 |
| Normal-VS-Unclassified PRCC |
7.637600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.530400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.136200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.454440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.570400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.966800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.973600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.510000E-01 |
| Normal-vs-N1 |
9.961000E-01 |
| Normal-vs-N2 |
1.920760E-01 |
| N0-vs-N1 |
4.769600E-01 |
| N0-vs-N2 |
8.927600E-01 |
| N1-vs-N2 |
5.516400E-01 |
|
|
